GenericsWeb Opens US Doors

1^st JULY 2008, Morristown, New Jersey. GenericsWeb, provider of premium Patent Intelligence Services to the Generic Pharmaceutical Industry, today opened the doors of its first US offices, strategically located in Morristown, New Jersey, the heart of the US pharmaceutical industry.

Geneva, Switzerland; Westerbork, The Netherlands, April 21, 2008

RidePharm and 4Vision today announced their alliance for the further development of their customer and product portfolio

The companies will work together to increase their opportunities across Europe and beyond. In this alliance they will combine their capacities and present and future assignments.
Particular emphasis will be given to the all aspects in the field of business development and advisory functions for Biotech and Pharma companies.

Public-Private Partnerships between EC and EFPIA

Under FP7, Joint Technology Initiatives (JTIs) have been introduced to realise Public-Private Partnerships in research at European level and IMI is one of the first JTIs. The EC and the European Federation of Pharmaceutical Industries and Associations (EFPIA) joined forces to set up IMI after the former has identified biomedical research as a strategy priority to enhance the competitiveness of the EU.

Open Innovation for Pharmaceutical Industry

Open Innovation is a term promoted by Henry Chesbrough, a professor and executive director at the Center for Open Innovation at Berkeley. The concept is related to (but distinct from) user innovation, cumulative innovation and distributed innovation.

The central idea behind open innovation is that in a world of widely distributed knowledge, companies cannot afford to rely entirely on their own research, but should instead buy or license processes or inventions (i.e. patents) from other companies.

Are you prepared for the coming gobal changes?

Medinfar, Portugal

Medinfar is a Pharmaceutical Company located in Portugal and with business in Portugal and African countries. Now, Medinfar is seeking for out-licensing its products around the world. Our politics for the business could be out-licensing, distribution, or other kind of contractual conditions that should be negociated.

Our core business are OTC, cosmeceutical and nutraceutical (sugar free) products.

For additional informations, please contact:

Julia Oliveira

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Social network websites: best practices from leading services

Getting Ready for WEB2.0 Pharma Marketing

Much has changed in the world of technology and marketing over the past several years. The pharmaceutical industry is certainly no exception to these trends as electronic marketing has forced many brand planners to rethink how their target audience accesses, uses, and shares branded and unbranded information in the electronic age.